[1] The Lancet Psychiatry. Global Burden of Disease 2021: mental health messages. Lancet Psychiatry, 2024; 11, 573. doi:  10.1016/S2215-0366(24)00222-0
[2] Ravindran A, Richter M, Jain T, et al. Functional connectivity in obsessive-compulsive disorder and its subtypes. Psychol Med, 2020; 50, 1173−81. doi:  10.1017/S0033291719001090
[3] Whitfield H, Hargreaves D, Nicholls D, et al. Risk factors of persistent adolescent thinness: findings from the UK Millennium Cohort Study. BMC Public Health, 2023; 23, 938. doi:  10.1186/s12889-023-15850-1
[4] Pampaloni I, Marriott S, Pessina E, et al. The global assessment of OCD. Compr Psychiatry, 2022; 118, 152342. doi:  10.1016/j.comppsych.2022.152342
[5] Stein DJ, Costa DLC, Lochner C, et al. Obsessive-compulsive disorder. Nat Rev Dis Primers, 2019; 5, 52. doi:  10.1038/s41572-019-0102-3
[6] Patti MA, Croen LA, Chen AM, et al. Prepregnancy BMI, gestational weight gain, and susceptibility to autism-related traits: the EARLI and HOME studies. Obesity, 2023; 31, 1415−24. doi:  10.1002/oby.23710
[7] Lee S, Byun MS, Yi D, et al. Body mass index and two-year change of in vivo Alzheimer's disease pathologies in cognitively normal older adults. Alzheimers Res Ther, 2023; 15, 108. doi:  10.1186/s13195-023-01259-w
[8] Rios JM, Miller AL, Lumeng JC, et al. Associations of maternal food addiction, dietary restraint, and pre-pregnancy BMI with infant eating behaviors and risk for overweight. Appetite, 2023; 184, 106516. doi:  10.1016/j.appet.2023.106516
[9] Abramovitch A, Anholt GE, Cooperman A, et al. Body mass index in obsessive-compulsive disorder. J Affect Disord, 2019; 245, 145−51. doi:  10.1016/j.jad.2018.10.116
[10] Subramaniam M, Picco L, He V, et al. Body mass index and risk of mental disorders in the general population: results from the Singapore Mental Health Study. J Psychosom Res, 2013; 74, 135−41. doi:  10.1016/j.jpsychores.2012.10.009
[11] Husky MM, Mazure CM, Ruffault A, et al. Differential associations between excess body weight and psychiatric disorders in men and women. J Womens Health, 2018; 27, 183−90. doi:  10.1089/jwh.2016.6248
[12] Stefan N. Causes, consequences, and treatment of metabolically unhealthy fat distribution. Lancet Diabetes Endocrinol, 2020; 8, 616−27. doi:  10.1016/S2213-8587(20)30110-8
[13] Mattar L, Thiébaud MR, Huas C, et al. Depression, anxiety and obsessive-compulsive symptoms in relation to nutritional status and outcome in severe anorexia nervosa. Psychiatry Res, 2012; 200, 513−7. doi:  10.1016/j.psychres.2012.04.032
[14] Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol, 2015; 44, 512−25. doi:  10.1093/ije/dyv080
[15] Hemani G, Zheng J, Elsworth B, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife, 2018; 7, e34408. doi:  10.7554/eLife.34408
[16] Elsworth B, Lyon M, Alexander T, et al. The MRC IEU OpenGWAS data infrastructure. bioRxiv, 2020.
[17] Mitchell R, Hemani G, Dudding T, et al. UK Biobank Genetic Data: MRC-IEU quality control, version 2. 2019.
[18] Kyle UG, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis—part I: review of principles and methods. Clin Nutr, 2004; 23, 1226−43. doi:  10.1016/j.clnu.2004.06.004
[19] Palmer TM, Lawlor DA, Harbord RM, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res, 2012; 21, 223−42. doi:  10.1177/0962280210394459
[20] Kurki MI, Karjalainen J, Palta P, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature, 2023; 613, 508−18. doi:  10.1038/s41586-022-05473-8
[21] Arnold PD, Askland KD, Barlassina C, et al. Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis. Mol Psychiatry, 2018; 23, 1181−8. doi:  10.1038/mp.2017.154
[22] Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: The STROBE-MR Statement. JAMA, 2021; 326, 1614−21. doi:  10.1001/jama.2021.18236
[23] Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol, 2017; 32, 377−89. doi:  10.1007/s10654-017-0255-x
[24] Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol, 2016; 40, 304−14. doi:  10.1002/gepi.21965
[25] Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol, 2017; 46, 1985−98. doi:  10.1093/ije/dyx102
[26] Larsson SC, Butterworth AS, Burgess S. Mendelian randomization for cardiovascular diseases: principles and applications. Eur Heart J, 2023; 44, 4913−24. doi:  10.1093/eurheartj/ehad736
[27] Bowden J, Del Greco MF, Minelli C, et al. Improving the accuracy of two-sample summary-data Mendelian randomization: moving beyond the NOME assumption. Int J Epidemiol, 2019; 48, 728−42. doi:  10.1093/ije/dyy258
[28] Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet, 2018; 50, 693−8. doi:  10.1038/s41588-018-0099-7
[29] Bowden J, Spiller W, Del Greco M F, et al. Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression. Int J Epidemiol, 2018; 47, 1264−78. doi:  10.1093/ije/dyy101
[30] Hübel C, Gaspar HA, Coleman JRI, et al. Genetic correlations of psychiatric traits with body composition and glycemic traits are sex- and age-dependent. Nat Commun, 2019; 10, 5765. doi:  10.1038/s41467-019-13544-0
[31] Abramovitch A, Mckay D. Behavioral impulsivity in obsessive-compulsive disorder. J Behav Addict, 2016; 5, 395−7. doi:  10.1556/2006.5.2016.029
[32] Park I, Ha MJ, Kim T, et al. Cortical gyrification differences between early- and late-onset obsessive-compulsive disorder: neurobiological evidence for neurodevelopmentally distinct subtypes. Psychol Med, 2023; 53, 5976−85. doi:  10.1017/S0033291722003129
[33] Perera MPN, Mallawaarachchi S, Bailey NW, et al. Obsessive-compulsive disorder (OCD) is associated with increased engagement of frontal brain regions across multiple event-related potentials. Psychol Med, 2023; 53, 7287−99. doi:  10.1017/S0033291723000843
[34] Blanco-Vieira T, Radua J, Marcelino L, et al. The genetic epidemiology of obsessive-compulsive disorder: a systematic review and meta-analysis. Transl Psychiatry, 2023; 13, 230. doi:  10.1038/s41398-023-02433-2
[35] Denzel D, Runge K, Feige B, et al. Autoantibodies in patients with obsessive-compulsive disorder: a systematic review. Transl Psychiatry, 2023; 13, 241. doi:  10.1038/s41398-023-02545-9
[36] Sandstrom A, Krause S, Ouellet-Courtois C, et al. What's control got to do with it? A systematic review of control beliefs in obsessive-compulsive disorder. Clin Psychol Rev, 2024; 107, 102372. doi:  10.1016/j.cpr.2023.102372
[37] Schuyler M, Geller DA. Childhood obsessive-compulsive disorder. Psychiatr Clin North Am, 2023; 46, 89−106. doi:  10.1016/j.psc.2022.10.002
[38] Levinson CA, Zerwas SC, Brosof LC, et al. Associations between dimensions of anorexia nervosa and obsessive-compulsive disorder: an examination of personality and psychological factors in patients with anorexia nervosa. Eur Eat Disord Rev, 2019; 27, 161−72. doi:  10.1002/erv.2635
[39] Abramovitch A, Pizzagalli DA, Geller DA, et al. Cigarette smoking in obsessive-compulsive disorder and unaffected parents of OCD patients. Eur Psychiatry, 2015; 30, 137−44.
[40] Pauls DL, Abramovitch A, Rauch SL, et al. Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective. Nat Rev Neurosci, 2014; 15, 410−24. doi:  10.1038/nrn3746
[41] Finucane HK, Reshef YA, Anttila V, et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat Genet, 2018; 50, 621−9. doi:  10.1038/s41588-018-0081-4
[42] Timpano KR, Schmidt NB, Wheaton MG, et al. Consideration of the BDNF gene in relation to two phenotypes: hoarding and obesity. J Abnorm Psychol, 2011; 120, 700−7. doi:  10.1037/a0024159
[43] Loos RJF, Bouchard C. FTO: the first gene contributing to common forms of human obesity. Obes Rev, 2008; 9, 246−50. doi:  10.1111/j.1467-789X.2008.00481.x
[44] Rivera M, COHEN-Woods S, Kapur K, et al. Depressive disorder moderates the effect of the FTO gene on body mass index. Mol Psychiatry, 2012; 17, 604−11. doi:  10.1038/mp.2011.45
[45] Zarza-Rebollo JA, Molina E, Rivera M. The role of the FTO gene in the relationship between depression and obesity. A systematic review. Neurosci Biobehav Rev, 2021; 127, 630−7. doi:  10.1016/j.neubiorev.2021.05.013
[46] Zai G, Barta C, Cath D, et al. New insights and perspectives on the genetics of obsessive-compulsive disorder. Psychiatr Genet, 2019; 29, 142−51. doi:  10.1097/YPG.0000000000000230
[47] Kajs BL, van Roessel PJ, Davis GL, et al. Valence processing alterations in SAPAP3 knockout mice and human OCD. J Psychiatr Res, 2022; 151, 657−66. doi:  10.1016/j.jpsychires.2022.05.024
[48] Nakao T, Okada K, Kanba S. Neurobiological model of obsessive-compulsive disorder: evidence from recent neuropsychological and neuroimaging findings. Psychiatry Clin Neurosci, 2014; 68, 587−605. doi:  10.1111/pcn.12195
[49] Zohar J, Kennedy JL, Hollander E, et al. Serotonin-1D hypothesis of obsessive-compulsive disorder: an update. J Clin Psychiatry, 2004; 65, 18−21.
[50] Moncrieff J, Cooper RE, Stockmann T, et al. The serotonin theory of depression: a systematic umbrella review of the evidence. Mol Psychiatry, 2023; 28, 3243−56. doi:  10.1038/s41380-022-01661-0
[51] Eissazade N, Mosavari H, Eghdami S, et al. Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: a systematic review and meta-analysis of randomized clinical trials. Sci Rep, 2023; 13, 20837. doi:  10.1038/s41598-023-47931-x
[52] Kałużna-Czaplińska J, Gątarek P, Chirumbolo S, et al. How important is tryptophan in human health?. Crit Rev Food Sci Nutr, 2019; 59, 72−88. doi:  10.1080/10408398.2017.1357534
[53] U-Din M, de Mello VD, Tuomainen M, et al. Cold-stimulated brown adipose tissue activation is related to changes in serum metabolites relevant to NAD+ metabolism in humans. Cell Rep, 2023; 42, 113131. doi:  10.1016/j.celrep.2023.113131
[54] Frank D, Gruenbaum BF, Shelef I, et al. Blood glutamate scavenging as a novel glutamate-based therapeutic approach for post-traumatic brain injury anxiety and social impairment. Transl Psychiatry, 2023; 13, 41. doi:  10.1038/s41398-023-02329-1
[55] Wang J, Hua GM, Wang SB, et al. Glutamatergic neurotransmission is affected by low-frequency repetitive transcranial magnetic stimulation over the supplemental motor cortex of patients with obsessive-compulsive disorder. J Affect Disord, 2023; 325, 762−9. doi:  10.1016/j.jad.2023.01.064
[56] Singer HS. Motor control, habits, complex motor stereotypies, and Tourette syndrome. Ann N Y Acad Sci, 2013; 1304, 22−31. doi:  10.1111/nyas.12281
[57] Zhao Q, Xu TT, Wang Y, et al. Limbic cortico-striato-thalamo-cortical functional connectivity in drug-naïve patients of obsessive-compulsive disorder. Psychol Med, 2021; 51, 70−82. doi:  10.1017/S0033291719002988
[58] Weeland CJ, Kasprzak S, de Joode NT, et al. The thalamus and its subnuclei—a gateway to obsessive-compulsive disorder. Transl Psychiatry, 2022; 12, 70. doi:  10.1038/s41398-022-01823-2
[59] Morigny P, Boucher J, Arner P, et al. Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics. Nat Rev Endocrinol, 2021; 17, 276−95. doi:  10.1038/s41574-021-00471-8
[60] Zhang X, Cai YY, Jiang YP, et al. Genetic correlation between circulating metabolites and chalazion: a two-sample Mendelian randomization study. Front Mol Biosci, 2024; 11, 1368669. doi:  10.3389/fmolb.2024.1368669